Great session by Tarry Ahuja, Director of our Post-Market Drug Evaluation program, on international collaboration on drug safety and effectiveness at #ICPE23.
🇨🇦 🤝🇺🇸
#PharmEpi#EpiTwitter#Pharmacoepidemiology#HTA
The CADTH Post-Market Drug Evaluation (PMDE) Program is looking for 2 industry representatives to be part of a task force aimed at identifying ways to mitigate risks and barriers to using industry real-world data. Check it out https://t.co/ZPFTNiTPcW
Always great collaborating with so many diverse perspectives. Congrats to the CanREValue team for leading this initiative. #CanREValue @CADTH_ACMTS #rwe
https://t.co/xJ4oBJLRoR
Very pleased that @CADTH_ACMTS can contribute to improving access to affordable and effective drugs for rare diseases. Money well spent!
https://t.co/CWfq8tDHvu
Never to early to start recruiting young scientists. Had a great time with these grade 5 kids getting to learn all about the brain. Way smarter than I was at ten! @CADTH_ACMTS @StGeorgeOCSB
@MrsJLawlor@StGeorgeOCSB It was a pleasure working with these kids! Love to see young brains in action. So many great questions and participation. Thanks grade 5 and Mrs. Lawlor.
@MrsJLawlor@StGeorgeOCSB It was a pleasure working with these kids! Love to see young brains in action. So many great questions and participation. Thanks grade 5 and Mrs. Lawlor.
International alignment on RWE guiding principles is one of the keys to better use and acceptance by HTA. Looking forward to chatting about this today at DIA RWE Conference #rwe22#pmde @CADTH_ACMTS
https://t.co/9RTS0ZjOa3
Happy Diwali to all! This festival of lights is anchored around family, blessings, and of course sweets. In these turbulent times it's great to pause and say thanks. #Diwali
After Halloween and Diwali, today is one of the most important days of the year. Today is World Evidence-Based Healthcare Day, a global initiative to highlight the critical role of evidence in improving health outcomes, enhancing clinical care, and informing policy. Enjoy safely!
Do you ever wonder how it's decided which medications you have access to? What is the role of the regulator, HTA, and provincial payer? This may help. @CADTH_ACMTS @INESSS_Qc@reformulary https://t.co/pCtptksjPo
Looking forward to talking about the future of RWE in our country today with @Mina__T and @DrJudithGlennie at the CAHR Market Access 201 session. @CAHR_ACRSS#PMDE#RWE
The cornerstone of CADTH's new Post-Market Drug Evaluation Program is CoLab—an evidence-generation network comprised of experts in applied research, drug evaluation methodologies, & data analysis from across Canada. Learn more about the CoLab network: https://t.co/5ERVygMmpJ
CADTH is pleased to announce the launch of its new Post-Market Drug Evaluation Program. This important initiative fills a key gap in Canada's drug safety and effectiveness landscape. Learn more: https://t.co/vng1RLpjgG
I'm very excited to share the launch of our new Post Market Drug Evaluation (PMDE) Program at CADTH today. This includes our new CoLab network made up of researchers, methodologists, and data analysts across our country. Check out the site to learn more at https://t.co/ONi2fimJtT
The Post-Market Drug Evaluation abilities of our country are about to change. Less than three weeks before CADTH and our new PMDE team launches! Stay tuned. @CADTH#PMDE#RWE
Our PMDE Team at CADTH is getting very excited to be launching our new PMDE program September 1st. We are looking to expand our team with another great player with experience in health outcomes research, epidemiology and real world evidence. Join us!
https://t.co/G82Li1MpjE